JDM Financial Group’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.8K Hold
135
﹤0.01% 186
2025
Q4
$11.5K Hold
135
﹤0.01% 176
2025
Q3
$10.5K Hold
135
﹤0.01% 190
2025
Q2
$10.6K Hold
135
0.01% 179
2025
Q1
$9.79K Hold
135
0.01% 179
2024
Q4
$9.99K Hold
135
0.01% 183
2024
Q3
$8.91K Hold
135
﹤0.01% 182
2024
Q2
$12.5K Hold
135
0.01% 136
2024
Q1
$12.9K Hold
135
0.01% 127
2023
Q4
$10.3K Hold
135
0.01% 131
2023
Q3
$9.35K Hold
135
0.01% 129
2023
Q2
$12.7K Hold
135
0.01% 118
2023
Q1
$11.2K Hold
135
0.01% 128
2022
Q4
$10.1K Buy
+135
New +$10.4K 0.01% 130

Other funds holding EW

JDM Financial Group's EW Position: Q1 2026 in Review

JDM Financial Group held its Edwards Lifesciences (EW) position steady in Q1 2026 at 135 shares worth $10.8K. The position accounts for ﹤0.01% of the portfolio, ranked #186.

JDM Financial Group first reported a position in EW in Q4 2022 and has held it in 14 quarters since. The position peaked at $12.9K in Q1 2024. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • JDM Financial Group held 135 shares of Edwards Lifesciences worth $10.8K as of Q1 2026.
  • JDM Financial Group left its Edwards Lifesciences share count unchanged in Q1 2026.
  • Edwards Lifesciences made up ﹤0.01% of JDM Financial Group's portfolio in Q1 2026, its #186 holding.
  • JDM Financial Group first reported a position in Edwards Lifesciences in Q4 2022 and has held it in 14 quarters since.
  • JDM Financial Group's Edwards Lifesciences position peaked at $12.9K in Q1 2024.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on JDM Financial Group's 13F filing for Q1 2026, filed 21 May 2026.